Gastrointestinal Tolerability Beyond Three Years Gastrointestinal effects remain the most common adverse events associated with GLP-1 receptor agonists
twice weekly, exhibited a significant reduction in alcohol consumption in comparison to the vehicle-treated control group
Important side effects to be aware of across this class include GI symptoms, osteonecrosis of the jaw (a rare but serious adverse effect involving bone death in the jaw that can be associated with dental procedures in patients on long-term bisphosphonates), and atypical femur fractures (Chandran et al., 2024)
With only the expensive name brand GLP-1s such as Wegovy and Zepbound, supplement companies have an opportunity to enter the market
morning administration of a GH injections with respect to sleep quality, duration, and daytime activity in an open-label, randomized, crossover design in children with GHD or idiopathic short stature (ISS)